| Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
|---|
| 01/31/2013 | WO2013014629A1 Pharmaceutical compositions comprising pyrrole diones and their use to inhibit angiogenesis |
| 01/31/2013 | WO2013014427A1 Compositions for treatment of skin disorders |
| 01/31/2013 | WO2013013799A1 Wound spray |
| 01/31/2013 | WO2013013609A1 Polymorphic forms of compounds as prolyl hydroxylase inhibitor, and uses thereof |
| 01/31/2013 | WO2013013501A1 Traditional chinese medicine composition for enhancing human immune function |
| 01/31/2013 | WO2012135812A3 Treatment for dermatological pathologies |
| 01/31/2013 | WO2012116210A3 Peptide for the induction of immune tolerance as treatment for systemic lupus erythematosus |
| 01/31/2013 | US20130030526 Crosslinked human or animal tissue products and their methods of manufacture and use |
| 01/31/2013 | US20130030055 Compositions and methods for treating hair loss, hair thinning, and hair color loss |
| 01/31/2013 | US20130030049 Methods of treating dermatological disorders or conditions |
| 01/31/2013 | US20130030030 Allantoin-containing skin cream |
| 01/31/2013 | US20130030014 N-(IMIDAZOLIDIN-2-YLIDENE)-HETEROCYCLOPENTA[b]PYRIDINE DERIVATIVES AS MODULATORS OF ALPHA 2 ADRENERGIC RECEPTORS |
| 01/31/2013 | US20130030008 Acylamino-substituted fused cyclopentanecarboxylic acid derivatives and their use as pharmaceuticals |
| 01/31/2013 | US20130030000 Pharmaceutical compositions for the treatment of pain and other indications |
| 01/31/2013 | US20130029999 Myosin light chain kinase inhibitor compounds, compositions and related methods of use |
| 01/31/2013 | US20130029995 Substituted Bicyclic Aromatic Carboxamide and Urea Compounds as Vanilloid Receptor Ligands |
| 01/31/2013 | US20130029994 N-(imidazolidin-2-ylidene)quinoline derivatives as modulators of alpha 2 adrenergic receptors |
| 01/31/2013 | US20130029990 Pyrazole p38 map kinase inhibitors |
| 01/31/2013 | US20130029985 Novel Compounds |
| 01/31/2013 | US20130029977 Fused substituted aminopyrrolidine derivative |
| 01/31/2013 | US20130029971 Cxcr3 receptor antagonists |
| 01/31/2013 | US20130029968 Indazoles |
| 01/31/2013 | US20130029962 Substituted Heteroaromatic Pyrazole-Containing Carboxamide and Urea Compounds as Vanilloid Receptor Ligands |
| 01/31/2013 | US20130029961 Substituted Heterocyclic Aza Compounds |
| 01/31/2013 | US20130029949 Substituted Quinolines and Their Use As Medicaments |
| 01/31/2013 | US20130029939 Novel glucokinase activators and methods of using same |
| 01/31/2013 | US20130029917 Use of a peptide hydrolysate of pea as moisturizing active agent |
| 01/31/2013 | US20130029915 Crosslinked human or animal tissue products and their methods of manufacture and use |
| 01/31/2013 | US20130029907 Novel Polypeptides That Bound to IL-23 Receptor and Inhibit Binding of IL-23 and Cell Signaling Thereof |
| 01/31/2013 | US20130029902 Cxc chemokine receptor 4 (cxcr4) antagonistic polypeptide |
| 01/31/2013 | US20130028993 Composition and Manufacturing Processes of a Toxicity Free Botanical Drug for Curative Treatment of Chronic Diseases |
| 01/31/2013 | US20130028987 Method of treating psoriasis |
| 01/31/2013 | US20130028986 Pharmaceutical Compositions |
| 01/31/2013 | US20130028980 Cell-polymer fiber compositions and uses thereof |
| 01/31/2013 | US20130028979 Stretch Marks Cream |
| 01/31/2013 | US20130028978 Compositions and methods for wound treatment |
| 01/31/2013 | US20130028975 Hemostatic sponge |
| 01/31/2013 | US20130028968 Compositions and methods to relieve chronic diseases symptoms |
| 01/31/2013 | US20130028962 Triggered Cargo Release from Nanoparticle Stabilized Liposomes |
| 01/31/2013 | US20130028952 Filler pigments |
| 01/31/2013 | US20130028947 Pharmaceutical composition for topical application |
| 01/31/2013 | US20130028923 Kdr peptides and vaccines comprising the same |
| 01/31/2013 | US20130028901 Novel receptor trem (triggering receptor expressed on myeloid cells) and uses thereof |
| 01/31/2013 | US20130028895 Exosome inhibiting agents and uses thereof |
| 01/31/2013 | US20130028894 Methods of treating il-tif associated inflammatory or immune diseases using antibodies against soluble zcytor 11 cytokine receptors |
| 01/31/2013 | US20130028887 Phenylacetic acid compound |
| 01/31/2013 | US20130028884 Composition and method for treatment of bruising |
| 01/31/2013 | US20130028881 Diagnosis and treatment of multiple sulfatase deficiency and other sulfatase deficiencies |
| 01/31/2013 | US20130028877 LACTOBACILLUS JOHNSONII La1 NCC533 (CNCM I-1225) AND IMMUNE DISORDERS |
| 01/31/2013 | US20130028870 Pluripotent stem cells and method of stimulating and extracting non-embryonic pluripotent stem cells from mammal blood and using reconstituted pluripotent stem cells to treat diseases including chronic obstructive pulmonary disease |
| 01/31/2013 | US20130028854 Osmoprotective Complexes for Prevention of Mitochondrial Free Radical Damage Related Skin Aging |
| 01/31/2013 | US20130028850 Topical tetracycline compositions |
| 01/31/2013 | US20130028849 Agent For Stimulating The Expression of Loxl |
| 01/31/2013 | US20130028843 Kallikrein 7 modulators |
| 01/31/2013 | CA2843431A1 Sandalwood oil and its uses related to skin disorders |
| 01/31/2013 | CA2843251A1 N-(imidazolidin-2-ylidene)quinoline derivatives as modulators of alpha 2 adrenergic receptors |
| 01/31/2013 | CA2842877A1 Pharmaceutical compositions comprising 4-bromo-n-(imidazolidin-2-ylidene)-1h-benzimidazol-5-amine for treating skin diseases |
| 01/31/2013 | CA2842730A1 Polymorphic forms of compounds as prolyl hydroxylase inhibitor, and uses thereof |
| 01/31/2013 | CA2842487A1 Wound spray |
| 01/31/2013 | CA2842337A1 Methods and compositions for treatment of epithelial wounds |
| 01/30/2013 | EP2551283A1 Anti-allergic agent |
| 01/30/2013 | EP2550973A1 Wound spray |
| 01/30/2013 | EP2550360A1 Bivalent antisense oligonucleotides |
| 01/30/2013 | EP2550002A1 Rna interference in dermal and fibrotic indications |
| 01/30/2013 | EP2549990A1 Compounds (cystein based lipopeptides) and compositions as tlr2 agonists used for treating infections, inflammations, respiratory diseases etc. |
| 01/30/2013 | CN102905719A Methods for treating combined radiation and thermal injury |
| 01/30/2013 | CN102905703A Compounds (cystein based lipopeptides) and compositions as TLR2 agonists used for treating infections, inflammations, respiratory diseases, etc. |
| 01/30/2013 | CN102905680A Cosmetic and pharmaceutical composition comprising n-acetylglucosamine-6-phosphate |
| 01/30/2013 | CN102899261A Isolated bifidobacterium longum subsp. longum capable of producing high cell immunity reaction |
| 01/30/2013 | CN102899227A Lung-heat clearing and whitening wine |
| 01/30/2013 | CN102898432A Tricyclic compound |
| 01/30/2013 | CN102898417A Benzo-hexahydric nitrogenous heterocycle derivative |
| 01/30/2013 | CN102898416A 5-substituted quinazolinone derivatives as anti-cancer agents |
| 01/30/2013 | CN102898381A Amine salts of a CRTH2 antagonist |
| 01/30/2013 | CN102898380A Amine salts of a CRTH2 antagonist |
| 01/30/2013 | CN102898364A Heterocyclic inhibitors of MEK and methods of use thereof |
| 01/30/2013 | CN102898349A Solid containing compound, a composition containing the solid and use of the solid |
| 01/30/2013 | CN102898284A 3-allyl-[1,1'-biphenyl]-4-phenol, derivatives, preparation methods and uses thereof |
| 01/30/2013 | CN102895637A Preparation method of medicinal bean for growing and blackening hair |
| 01/30/2013 | CN102895636A Preparation method for drug, ginger-garlic ointment, for treating chilblain |
| 01/30/2013 | CN102895630A Preparation technology and production method for integrated new formulation of astragalus and cinnamon twig five agents decoction |
| 01/30/2013 | CN102895627A Preparation technology and production method for integrated new formulation of radix bupleuri, cassia twig and dry ginger decoction |
| 01/30/2013 | CN102895620A Preparation technology and production method for integrated new formulation of licorice heart-draining decoction |
| 01/30/2013 | CN102895619A Preparation technology and production method for integrated new formulation of belamcanda rhizome and ephedra decoction |
| 01/30/2013 | CN102895618A Preparation technology and production method for integrated new formulation of snakegourd root and cassia twig decoction |
| 01/30/2013 | CN102895617A Preparation technology and production method for integrated new formulation of bighead atractylodes rhizome and monkshood decoction |
| 01/30/2013 | CN102895613A Preparation technology and production method for integrated new formulation of cassia twig plus kudzu root decoction |
| 01/30/2013 | CN102895608A Chinese medicinal composition with bleeding arresting and pain relieving functions and its preparation method |
| 01/30/2013 | CN102895575A Medicine composition for treating rashes as well as preparation method and application thereof |
| 01/30/2013 | CN102895558A Chinese medicine for treating allergic dermatitis |
| 01/30/2013 | CN102895553A Preparation technology and production method for integrated new formulation of ephedra, apricot kernel, coix and licorice decoction |
| 01/30/2013 | CN102895548A Composition with effects of clearing away heat, purging pathogenic fire and removing toxin and preparation method thereof |
| 01/30/2013 | CN102895542A Medicine for treating infant skin fold ulcer |
| 01/30/2013 | CN102895532A Traditional Chinese medicine composition for treating alopecia areata |
| 01/30/2013 | CN102895527A Chinese medicinal external preparation for treating bedsore |
| 01/30/2013 | CN102895526A Externally-applied skin-generating oil for treatment of burn and preparation method and application thereof |
| 01/30/2013 | CN102895517A Method for preparing qi-tonifying and hair-blacking medicine, and medicine prepared by using same method |
| 01/30/2013 | CN102895509A Medicine composition for treating rash diseases as well as preparation method and application thereof |
| 01/30/2013 | CN102895507A Chinese medicine for treating leukoplakia vulvae and preparation method thereof |
| 01/30/2013 | CN102895497A Preparation technology and production method for integrated new formulation of lily and radix rehmanniae decoction |